The plan addresses substances that are suspected of posing risks to human health or the environment. The substance evaluation process allows the clarification of such risks by requests for additional information to the registrants.
The draft update for 2014-2016 has been prepared in close cooperation with the Member States, taking into account the agreed risk-based criteria for the selection of substances. The Member States have also proposed substances based on national priorities. 22 Member States will take part in the substance evaluation work in the coming three years.
In many cases, the initial concerns are related to potential persistent, bioaccumulative and toxic properties, suspected endocrine disruption or carcinogenic, mutagenic and reprotoxic properties in combination with wide dispersive or consumer use(s). In general, the uses of these substances cover various areas and do not focus on any particular industrial, professional or consumer uses.
ECHA has submitted the draft CoRAP update for 2014-2016 to the Member State competent authorities and the Member State Committee. The Committee starts its discussions this week and will prepare an opinion on the draft plan in February 2014. ECHA will then adopt the final CoRAP update for 2014-2016 on the basis of the Committee's opinion.
The CoRAP process does not include a public consultation. However, ECHA informs the stakeholders of the progress made by publishing this draft list of substances and encourages registrants of the substances to start coordinating their actions and to have early interactions with the evaluating Member States.
ECHA's aim is to adopt and publish the final CoRAP update for 2014-2016 in March 2014. The final CoRAP update for 2014-2016 will indicate the Member State responsible for the evaluation of each substance and the initial reasons of concern.
From the publication of the final CoRAP update for 2014-2016, the respective Member States have one year to evaluate the 56 substances specified for 2014 and, where regarded as necessary, to prepare a draft decision for requesting further information to clarify the suspected risks.
Such draft decisions will be reviewed by the other Member States and ECHA and when necessary agreed by the Member State Committee before ECHA issues a final decision. Registrants of substances listed on the final CoRAP will be given an opportunity to comment before any final decision to request further information is taken.
European Chemicals Agency
Textiles | On 24th Jul 2017
Complete value chain of garment and textile manufacturing solutions...
Apparel/Garments | On 23rd Jul 2017
Abercrombie & Fitch has announced the launch of Abercrombie & Fitch...
Apparel/Garments | On 23rd Jul 2017
The National Retail Federation has urged Congress to reject a...
Angelina Francesca Cheang
'Consumers in the age-group 21 to 38 are driving the activewear trend'
The S Studio
Ethnicwear market will see an upward trend if uniqueness and quality are...
Varinder Singh Jawanda
Sizing and fitting issues are inherent problems for companies expanding...
Swerea IVF AB
Marten Alkhagen, Senior Scientist - Nonwoven and Technical Textiles of...
Biovation II LLC
Kerem Durdag, CEO, Biovation II LLC, provides an insight into future...
Voith Paper GmbH & Co. KG
The glass mat industry is growing by five to eight per cent annually. Kai...
Hyderabad-based designer <b>Prathyusha Garimella</b> is known for blending ...
Yash P. Kotak
Bombay Hemp Company
One of the directors of Bombay Hemp Company, Yash P. Kotak, speaks to...
Somaiya Kala Vidya
Among the many honours showered on Frater, including Fulbright and Ford...
Textiles | On 21st Jul 2017
Do you think the sustainability space has the needed tools and resources available for a business to lead change?Yes No Skip
Do you think adopting a sustainable approach will be a profitable move for your business?Yes No Skip
Do you want the world to know about your sustainability journey and your business’ environmental footprint?Yes No Skip
Thanks for your valuable feedback. Claim your free latest sustainability e-book.